UnknownPhase 4

Levetiracetam Versus Phenytoin in Management of Pediatric Status Epilepticus

Egypt60 participantsStarted 2019-01-01

Plain-language summary

The study will be conducted on 60 children suffering from status epilepticus who will be admitted to Pediatric Neurology Unit and Pediatric ICU of Tanta Hospital University.

Who can participate

Age range30 Days – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children suffering from convulsive generalized tonic clonic status epilepticus at any age. Exclusion Criteria: * Non convulsive status epilepticus. * Children with known contraindication or allergy to levetireacetam or phenytoin.

What they're measuring

cessation of convulsion

Timeframe: 30 minutes

Trial details

NCT IDNCT04176887

SponsorTanta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-02-01

Contact for this trial

Amira Darwish, MD

+1026380311 amira.darwish@med.tanta.edu.eg

View on ClinicalTrials.gov More Comparison trials